BASKHANBIOPharma Inc.
Founded 1986, KONEX-listed since 2022, BASKHANBIOPharma makes drugs and medical devices for use before and after surgery.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureBASKHANBIOPharma Inc. was founded in 1986 as Hanbul Pharmaceutical Co., listed on KONEX in 2022, and took its current name after LegoChem BioSciences acquired it in 2015 (renaming it LegoChem Pharma) and it merged with Medizone Co. in 2020. BAS in its English name stands for 'Before After on Surgery,' reflecting its core business of manufacturing and selling prescription and over-the-counter drugs and medical devices used before, during, and after surgery. The company obtained pharmaceutical manufacturing GMP in 2017 and medical device manufacturing GMP in 2020, and plans to expand its portfolio with non-reimbursed drugs, injectables, and hemostatic agents to increase operating profit.
Regulatory approvals
data.go.kr151 Korean MFDS drug approvals · 1986–2026 / 6 Korean MFDS device approvals · 2018–2023
- MFDS drugDiabelin Tab.2026-08-13Drug · OTC · Notification202602371
- MFDS drugCelvadi Tab.2026-04-21Drug · OTC · Notification202601150
- MFDS drugDikarec Alfa Tab. 1μg2026-04-01Drug · OTC · Notification202600927
- MFDS drugVitapulse Tab.2025-12-09Drug · OTC · Notification202503210
- MFDS drugDikarec D Plus Tab.2025-12-02Drug · OTC · Notification202503148
- MFDS drugPanteol Cream2025-08-18Drug · OTC · Notification202502135
- MFDS drugBerota A Tab.2025-07-30Drug · OTC · Notification202501990
- MFDS drugTeravita F Soft Cap.2025-06-12Drug · OTC · Notification202501440
- MFDS drugPowervita F Soft Cap.2025-04-30Drug · OTC · Notification202501058
- MFDS drugLergyperine Tab.2025-04-29Drug · OTC · Notification202501032
- MFDS drugCalandy Tab.2025-03-31Drug · OTC · Notification202500732
- MFDS drugFurphen M Tab.2025-01-15Drug · OTC · Notification202500121
Show 68 more
- MFDS drugFurphen F Tab.2025-01-15Drug · OTC · Notification202500122
- MFDS drugDikarec Max Tab.2024-12-12Drug · OTC · Notification202402944
- MFDS drugLupien Eve Soft Cap.2024-11-11Drug · OTC · Notification202402670
- MFDS drugGinkgo Tab. 240mg2024-11-11Drug · OTC · Notification202402669
- MFDS drugRisbium Tab.2024-10-07Drug · OTC · Notification202402385
- MFDS drugMyall Tab.2024-10-02Drug · OTC · Notification202402367
- MFDS drugWon Line Tab.2024-09-19Drug · OTC · Notification202402252
- MFDS drugWon Line Semi Tab.2024-09-19Drug · OTC · Notification202402253
- MFDS drugMelatry Tab.2024-08-30Drug · OTC · Notification202402098
- MFDS drugLilexa S Tab.2024-05-29Drug · OTC · Notification202401338
- MFDS drugSsakfreen Susp.2023-06-21Drug · OTC · Notification202301911
- MFDSEndotherapy cannula, single-use2023-04-26Product approval · Class 2제인 23-4674 호
- MFDS drugTalus Cream2023-04-20Drug · OTC · Notification202301297
- MFDSEndotherapy cannula, single-use2023-04-19Product approval · Class 2제인 23-4645 호
- MFDS drugTomuse Soft Cap.2023-04-13Drug · OTC · Notification202301227
- MFDS drugMysok Tab.2023-03-29Drug · OTC · Notification202301043
- MFDS drugL-carec Sol.2022-12-23Drug · OTC · Notification202204616
- MFDS drugViDkhan Inj. (Cholecalciferol)2022-10-12Drug · Prescription · Notification202203815
- MFDS drugBrikhan Inj. (Sugammadex sodium)2022-07-19Drug · Prescription · Approval202202969
- MFDS drugMaynol Tab.2022-01-03Drug · OTC · Notification202200014
- MFDSGraft/prosthesis, biomaterial2021-11-15Product approval · Class 4제허 21-907 호
- MFDS drugMay-Q Tab.Revoked2021-06-23Drug · OTC · Notification202104806
- MFDS drugL-camin Tab.2021-06-03Drug · OTC · Notification202104347
- MFDS drugHepabeat D Soft Cap.2021-05-07Drug · OTC · Notification202103714
- MFDS drugMaysen Tab.Revoked2021-03-09Drug · OTC · Notification202102170
- MFDS drugAlmitin Plus Tab.2020-09-15Drug · OTC · Notification202006366
- MFDS drugLupien Soft Cap.2020-07-29Drug · OTC · Notification202005496
- MFDSDressing, adhesion barrier2020-04-03Product approval · Class 3제허 20-249 호
- MFDS drugTopamak Tab. 25mg2020-01-03Drug · Prescription · Approval202000046
- MFDS drugAlmitangel Tab.2019-11-07Drug · OTC · Notification201907790
- MFDS drugAnerwell Tab.2019-10-18Drug · OTC · Notification201907340
- MFDS drugLosatine Tab. 50mgRevoked2019-08-19Drug · Prescription · Approval201905844
- MFDS drugAlbichem Tab.Revoked2019-07-02Drug · Prescription · Approval201904508
- MFDS drugL-carec Tab.2019-06-25Drug · OTC · Notification201904337
- MFDS drugFurphen Tab.Revoked2019-06-12Drug · OTC · Notification201903830
- MFDS drugSowaen Tab.2019-06-04Drug · OTC · Notification201903734
- MFDS drugRetova Tab. 10mg2019-05-16Drug · Prescription · Approval201903183
- MFDS drugBaflozine Cap.2019-05-16Drug · Prescription · Approval201903186
- MFDS drugRetova Tab. 20mg2019-04-30Drug · Prescription · Approval201902796
- MFDS drugEviehill Tab.Revoked2019-04-29Drug · Prescription · Approval201902748
- MFDSEndoscopic trocar, single use2019-04-25Product approval · Class 2제인 19-4320 호
- MFDS drugFinasterine Tab. 5mg2019-03-29Drug · Prescription · Approval201901926
- MFDS drugReito Tab. 50mgRevoked2019-03-26Drug · Prescription · Approval201901790
- MFDS drugCebrec Cap. 100mg2019-03-25Drug · Prescription · Approval201901768
- MFDS drugMoreable Tab. 1mg2019-03-11Drug · Prescription · Approval201901476
- MFDS drugDikarec Tab.2019-03-06Drug · OTC · Notification201901368
- MFDS drugDucla Tab. 375mgRevoked2019-02-20Drug · Prescription · Approval201901047
- MFDS drugDucla Duo Tab. 500mgRevoked2019-02-20Drug · Prescription · Approval201901051
- MFDS drugTreco Tab.Revoked2019-02-14Drug · OTC · Notification201900930
- MFDS drugPowerssen Soft Cap.2019-01-30Drug · OTC · Notification201900736
- MFDS drugBistar Tab.2018-11-13Drug · OTC · Notification201804495
- MFDSAbrasive deviceRevoked2018-11-09Product approval · Class 1제신 18-1512 호
- MFDS drugMedicon 600 Tab.2018-08-01Drug · OTC · Notification201803183
- MFDS drugAlleon Tab.2018-07-12Drug · Prescription · Approval201802900
- MFDS drugLosatine Plus F Tab.2018-06-22Drug · Prescription · Approval201802623
- MFDS drugNorvaforce Tab.2018-06-15Drug · Prescription · Approval201802475
- MFDS drugZembio Cap.2018-06-05Drug · OTC · Notification201802335
- MFDS drugBonbaro inj. (Ibandronate sodium monohydrate)2018-04-27Drug · Prescription · Notification201801801
- MFDS drugVitilec Cap.2018-02-20Drug · OTC · Notification201800864
- MFDS drugFerro-Q Cap.2018-02-08Drug · OTC · Notification201800754
- MFDS drugThiuracil Tab.2018-01-11Drug · Prescription · Approval201800174
- MFDS drugDamycin Cap. 300mg2017-10-26Drug · Prescription · Notification201707609
- MFDS drugOpalec Tab.2017-07-19Drug · Prescription · Approval201705763
- MFDS drugLosatine Tab. 100mg2017-06-29Drug · Prescription · Approval201704862
- MFDS drugPowerking Soft Cap.2017-05-01Drug · OTC · Notification201702265
- MFDS drugLerica Cap. 150mg2017-04-27Drug · Prescription · Approval201702148
- MFDS drugLerica Cap. 75mg2017-04-27Drug · Prescription · Approval201702149
- MFDS drugUrsocol Tab.2017-03-20Drug · Prescription · Notification201701351
Showing the 80 most recent of 157 records.
Clinical trials
data.go.kr4 MFDS clinical trial authorisations · 2019–2020 (Bioequivalence 4)
- Bioequivalence레페리손정(에페리손염산염)2020-03-18
2 trial sites
- Bioequivalence레고렉스캡슐200밀리그램(세레콕시브)2019-08-19
2 trial sites
- Bioequivalence레고모틴정5밀리그램(모사프리드시트르산염수화물)2019-08-08
2 trial sites
- Bioequivalence레고켐콜린알포세레이트연질캡슐(콜린알포세레이트)2019-05-27
2 trial sites
Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Founded and KOSDAQ-listed in 2018, WSI distributes spine/joint devices and has expanded into medical robots and pharma via subsidiaries.
Founded in 2003 and KOSDAQ-listed in 2021, BioPlus develops HA-based bio medical devices and biopharmaceuticals using its proprietary MDM Technology platform.
Founded and listed on the KOSDAQ in 2016, BNC Korea is a biohealthcare company specializing in HA fillers, botulinum toxin, and dermo-cosmetics.
KOSDAQ-listed medical device company manufacturing synthetic bioresorbable suture yarn and dental root canal filling materials.
KOSDAQ-listed medical device company producing PDRN pharmaceuticals, HA fillers, and Rejuran-branded cosmetics.
KOSDAQ-listed pharmaceutical and healthcare company producing lidocaine anesthetics and the Kynix hyaluronic-acid eye-drop line.
KOSDAQ-listed healthcare company selling the Cissus weight-management ingredient and Sallimbaekseo household products.
KOSPI-listed pharmaceutical company behind the combination drugs Amosartan (hypertension) and Rosuzet (dyslipidemia).
KOSDAQ-listed medical device maker producing disposable acupuncture needles, cupping cups, and hyaluronic acid dermal fillers.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed operating holding company of the Hanmi Pharm group, also running healthcare and pharmaceutical wholesale businesses.
A pharmaceutical company supplying antifungal and urology drugs to clinics, co-marketing original drugs together with JW Pharmaceutical.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition